Design of mechanism-based carboxypeptidase A inactivators on the basis of the X-ray crystal structure and catalytic reaction pathway

Bioorganic and Medicinal Chemistry

Volumn 6, Issue 9, 1998, Pages 1613-1622

  Lee, Kyung Joo ^a   Kim, Dong H ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE A; ENZYME INHIBITOR;

ARTICLE; CATALYSIS; CHEMICAL REACTION; DRUG DESIGN; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME KINETICS; X RAY CRYSTALLOGRAPHY;

BINDING SITES; CARBOXYPEPTIDASES; CARBOXYPEPTIDASES A; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0032168118     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(98)00082-0     Document Type: Article

References (54)

1. A preliminary account of this work has been published: Kim, D. H.; Lee, K. J. Bioorg. Med. Chem. Lett. 1997, 7, 2607-2612.
2. (a) The Enzymes, Boyer, P. D., Academic Press, New York, 1971, Vol. III.
3. (b) Fersht, A. Enzyme Structure and Mechanism, 2nd edn; W. H. Freeman Co.: Cambridge, England, 1984: pp 405-426.
4. (a) Protease Inhibitors; Barrett, A. J.; Salvesen, G. Eds.; Elsevier: Amsterdam, 1986.
5. (b) Rich, D. H. In Comprehensive Medicinal Chemistry; Hansch, C.; Sammes, P. C.; Taylor, J. B. Eds.; Pergamon Press: Oxford, 1990; Vol. 2, pp 391-441.
6. (c) Fischer, G. Nat. Prod. Rep. 1988, 465-495.
7. (d) Walpole, C. S. J.; Wrigglesworth, R. Nat. Prod. Rep. 1989, 311-346.
8. (a) Quiocho, F. A.; Lipscomb, W. N. Adv. Prot. Chem. 1971, 25, 1-78.
9. (b) Christianson, D. W.; Lipscomb, W. N. Acc. Chem. Res. 1989, 22, 62-69.
10. (c) Lipscomb, W. N.; Sträter, N. Chem. Rev. 1996, 96, 2375-2433.
11. (a) Ondetti, M. A.; Rubin, R.; Cushman, D. W. Science, 1977, 196, 441-444.
12. (b) Cushman, D. W.; Cheung, H. S.; Sabo, E. F.; Ondetti, M. A. Biochemistry 1977, 16, 5484-5941.
13. (c) Patchett, A. A.; Harris, E.; Tristram, R. W.; Wyvratt, M. J.; Wu, M. T.; Taub, D.; Peterson, E. R.; Ikeler, T. J.; ten Broeke, J.; Payne, L. G.; Ondeyka, D. L.; Thorsett, E. D.; Greenlee, W. J.; Lohr, N. S.; Hoffsommer, R. D.; Joshua, H.; Ruyle, W. V.; Rothrock, J. W.; Aster, S. D.; Maycock, A. L.; Robinson, F. M.; Hirschman, R.; Sweet, C. S.; Ulm, E. H.; Gross, D. M.; Vassil, T. C.; Stone, C. A. Nature (London) 1980, 288, 280-283.
14. (d) Gafford, J. T.; Skidgel, R. A.; Erdos, E. G.; Hersh, L. B. Biochemistry 1983, 22, 3265-3271.
15. (e) Kim, D. H.; Guinosso, C. J.; Buzby, Jr., G. C.; Herbst, D. R.; McCaully, R. J.; Wicks, T. C. J. Med. Chem. 1983, 26, 394-403.
16. (a) Redshaw, S. In Medicinal Chemistry, 2nd edn, Roberts, S. M; Ganellin, C. R. Eds; Academic Press, San Diego, CA, 1993, pp 163-186.
17. (b) Whal, R. C.; Dunlap, R. P. Ann. Rep. Med. Chem. 1989, 25, 177-184.
18. (c) Hagman, W. K.; Lark, M. W.; Becker, J. Ann. Rep. Med. Chem. 1996, 31, 231-240.
19. Kim, D. H.; Kim, K. S.; Park, J. K. Bull. Korean Chem. Soc. 1994, 15, 805-807.
20. Izmiya, N.; Uchio, H. J. Biochem. 1959, 46, 235-245.
21. (a) Rees, D. C.; Lewis, M.; Honzatko, R. B.; Lipscomb, W. N.; Hardman, K. D. Proc. Natl. Acad. Sci. U.S.A. 1981, 78, 3408-3412.
22. (b) Mackenzie, N. E.; Fagerness, P. E.; Scott, A. I. J. Chem. Soc., Chem. Commun. 1985, 635-637.
23. (c) Christianson, D. W.; Lipscomb, W. N. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 7568-7572.
24. (a) Makinen, M. W.; Yamamura, K.; Kaiser, E. T. Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 3882-3886.
25. (b) Makinen, M. W.; Kuo, L. C.; Dymowski, J. J. J. Biol. Chem. 1979, 254, 356-366.
26. (c) Kuo, L. C.; Makinen, M. W. J. Biol. Chem. 1982, 257, 24-27.
27. (d) Suh, J.; Hong, S.-B.; Chung, S. J. Biol. Chem. 1986, 261, 7112-7114.
28. (e) Suh, J.; Cho, W.; Chung, S. J. Am. Chem. Soc. 1985, 107, 4530-4535.
29. (f) Sander, M. E.; Witzel, H. Biochem. Biophys. Res. Commun. 1985, 132, 681-687.
30. (g) Britt, B. M.; Peticolas, W. L. J. Am. Chem. Soc. 1992, 114, 5295-5303.
31. (a) Breslow, R.; Wernick, D. L. Proc. Natl. Acad. Sci. U.S.A. 1977, 74, 1303-1307.
32. (b) Breslow, R.; Wernick, D. L. J. Am. Chem. Soc. 1976, 98, 259-261.
33. (c) Nau, H.; Riordan, J. F. Biochemistry 1975, 14, 5285-5294.
34. (d) Galdes, A.; Auld, D. S.; Vallee, B. L. Biochemistry 1983, 22, 1888-1893.
35. (e) Galdes, A.; Auld, D. S.; Vallee, B. L. Biochemistry 1986, 25, 646-651.
36. (f) Breslow, R.; Shepartz, A. Chem. Lett. 1987, 1-4.
37. The slow hydrolysis of Gly-Tyr was attributed to the formation of a salt bridge between the carboxylate of Glu-270 and the terminal amino group of the ligand.
38. Hass, G. M.; Neurath, H. Biochemistry 1971, 10, 3535-3540.
39. Suh, J.; Kaiser, E. T. J. Am. Chem. Soc. 1976, 98, 1940-1947.
40. (a) Beyers, L. D.; Wolfenden, R. Biochemistry 1973, 12, 2070-2078.
41. (b) Beyers, L. D.; Wolfenden, R. J. Biol. Chem. 1972, 247, 606-608.
42. Kitz, R.; Wilson, I. B. J. Biol. Chem. 1962, 237, 3245-3249.
43. Lee, S. S.; Li, Z.-H.; Lee, D. H.; Kim, D. H. J. Chem. Soc. Perkin Trans. 1, 1995, 2877-2882.
44. Levy, H. M.; Leber, P. D.; Ryan, E. M. J. Biol. Chem. 1963, 238, 3654-3659.
45. Silverman, R. Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology; CRC: Boca Raton, FL, 1988; Vol. I, pp 22-23.
46. Dixon, M. Biochem. J. 1953, 55, 170-171.
47. (a) Kim, D. H.; Kim, K. B. J. Am. Chem. Soc. 1991, 113, 3200-3202.
48. (b) Yun, M.; Park, C.; Kim, S.; Nam, D.; Kim, S. C.; Kim, D. H. J. Am. Chem. Soc. 1992, 114, 2281-2282.
49. (c) Ryu, S.-E.; Choi, H.-J.; Kim, D. H. J. Am. Chem. Soc. 1997, 119, 38-41.
50. Massova, I.; Martin, P.; Mel, S.; Tanaka, Y.; Edwards, B.; Mobashery, S. J. Am. Chem. Soc. 1996, 118, 12479-12480.
51. Banci. L.; Bertini, I.; La Penna, G. Proteins: Structure, Funtions, Genetics 1994, 18, 186-197.
52. Labia, R.; Lelievre, V.; Peduzzi, J. Biochim. Biophys. Acta 1980, 611, 351-357.
53. We observed that Gly-L-Phe and Gly-L-phenyllactic acid undergo exclusive hydrolytic cleavage when incubated with CPA, suggesting that they are not inhibitors but substrates for CPA.
54. Stahmann, M.; Fruton, J. S.; Bergmann, M. J. Biol. Chem. 1946, 164, 753-760.